Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Coralie Cantarel
Observed names:
C Cantarel,
C. Cantarel,
Cantarel, Coralie
Institutions:
Centre Hospitalier Universitaire de Grenoble,
Hôpital Couple Enfant
Observed institutions:
Université de Bordeaux,
Inserm,
Centre Hospitalier Universitaire de Grenoble,
Hôpital Couple Enfant,
Bordeaux Population Health,
Institut Bergonié,
Centre d'Investigation Clinique Plurithématique de Bordeaux
show all 7
OpenAlex ID:
A5073345270
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort
2022
·
A. Italiano
, A. Bessede
, et al.
·
Nature Medicine
·
310
Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial
2021
·
Sophie Cousin
, Coralie Cantarel
, et al.
·
Clinical Cancer Research
·
158
PDF
Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
2022
·
Sophie Cousin
, Coralie Cantarel
, et al.
·
European Journal of Cancer
·
59
PDF
Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
2022
·
Maud Toulmonde
, Sophie Cousin
, et al.
·
Journal of Hematology & Oncology
·
56
PDF
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide
2024
·
Maud Toulmonde
, Jean-Philippe Guegan
, et al.
·
Molecular Cancer
·
52
PDF
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics
2024
·
Sophie Cousin
, Jean-Philippe Guégan
, et al.
·
Molecular Cancer
·
48
PDF
REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort.
2020
·
Sophie Cousin
, Carine A. Bellera
, et al.
·
Journal of Clinical Oncology
·
35
PD1 inhibition in soft-tissue sarcomas with tertiary lymphoid structures: A multicenter phase II trial.
2021
·
Antoine Italiano
, Alban Bessede
, et al.
·
Journal of Clinical Oncology
·
24
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab
2025
·
Maud Toulmonde
, Jean-Philippe Guégan
, et al.
·
Signal Transduction and Targeted Therapy
·
23
PDF
Bone Uptake in Prostate Cancer Patients: Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence
2022
·
Anouk Letang
, Amandine Crombé
, et al.
·
Clinical Nuclear Medicine
·
22
Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer
2022
·
Sophie Cousin
, Maud Toulmonde
, et al.
·
Experimental Hematology and Oncology
·
18
PDF
Anastomotic leakage and functional outcomes following total mesorectal excision with delayed and immediate colo-anal anastomosis for rectal cancer: Two single-arm phase II trials
2023
·
Serge Evrard
, Carine Bellera
, et al.
·
European Journal of Surgical Oncology
·
14
PDF
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis
2025
·
Sophie Cousin
, Jean-Philippe Guégan
, et al.
·
Nature Cancer
·
12
Regomune: A phase II study of regorafenib + avelumab in solid tumors—Results of the biliary tract cancer (BTC) cohort.
2021
·
Sophie Cousin
, Carine A. Bellera
, et al.
·
Journal of Clinical Oncology
·
10
Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study
2025
·
Thomas Grellety
, Carine Bellera
, et al.
·
Journal of Geriatric Oncology
·
6
Abstract CT033: Avelumab combined with regorafenib in solid tumors with tertiary lymphoid structures: A phase 2 REGOMUNE trial cohort
2024
·
Antoine Italiano
, Sophie Cousin
, et al.
·
Cancer Research
·
6
1494P Regomune - a phase II study of regorafenib + avelumab in solid tumors: Results of the soft tissue sarcoma (STS) cohort
2022
·
S. Cousin
, C. Bellera
, et al.
·
Annals of Oncology
·
6
PDF
REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the oesophageal or gastric carcinoma (OGC) cohort.
2022
·
Sophie Cousin
, Jean Philippe Metges
, et al.
·
Journal of Clinical Oncology
·
6
Incidence and prognostic factors of clinically meaningful toxicities of kinase inhibitors in older patients with cancer: The PreToxE study
2020
·
Coriolan Lebreton
, Coralie Cantarel
, et al.
·
Journal of Geriatric Oncology
·
6
Predicting severe toxicity of targeted therapies in elderly patients with cancer (PreToxE): A multicenter, prospective, and retrospective study.
2019
·
Coriolan Lebreton
, Coralie Cantarel
, et al.
·
Journal of Clinical Oncology
·
5
1925MO Regomune study: A phase II study of regorafenib + avelumab in solid tumors. Results of the radioiodine-refractory differentiated thyroid cancer (RR-DTC)
2024
·
Y. Godbert
, S. Cousin
, et al.
·
Annals of Oncology
·
2
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-VEGFR targeted therapy: A Phase 2 Trial of Regorafenib combined with avelumab.
2024
·
Antoine Italiano
, Jean-Philippe Guegan
, et al.
·
Journal of Clinical Oncology
·
2
Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison
2023
·
Nicolas Penel
, Coralie Cantarel
, et al.
·
Therapeutic Advances in Medical Oncology
·
1
PDF
Abstract 2578: High regulatory T cells infiltrate within tertiary lymphoid structure restricts response to immune checkpoint blockers in sarcomas
2022
·
Florent Peyraud
, Jean-Philippe Guegan
, et al.
·
Cancer Research
·
1
Metzolimos metronomic cyclophosphamide (CP) and methotrexate (MTX) combined with zoledronic acid (ZA) and sirolimus (SIR) in patients with advanced solid tumor with bone metastasis and advanced pretreated osteosarcoma (OSS): A phase Ib study.
2022
·
Maud Toulmonde
, Perrine Marec-Berard
, et al.
·
Journal of Clinical Oncology
·
1
Show more works
View as search
Works count:
46
Citation count:
883
H-index:
12
I10-index:
14
Year
Topic
Type